Cell Signaling Technology

Phospho-AMPA Receptor 2 (GluA2) (Tyr876) Antibody

#4027 · $362

100
Citing papers
10.9k
Combined citations
Supplier page Find this product

Research areas

Immune cells in cancer7RNA Research and Splicing7Neurogenesis and neuroplasticity mechanisms7PI3K/AKT/mTOR signaling in cancer7Cancer, Hypoxia, and Metabolism6Cancer-related molecular mechanisms research6RNA modifications and cancer6Autophagy in Disease and Therapy5

Papers citing this product

1
Diverse stimuli engage different neutrophil extracellular trap pathways
eLife·2017·783 cit.·DOI
2
Genome-wide analysis of long noncoding RNA stability
Genome Research·2012·585 cit.·DOI
3
Induction of Proinflammatory Responses in Macrophages by the Glycosylphosphatidylinositols of Plasmodium falciparum
Journal of Biological Chemistry·2004·482 cit.·DOI
4
Akt Signals through the Mammalian Target of Rapamycin Pathway to Regulate CNS Myelination
Journal of Neuroscience·2009·321 cit.·DOI
5
Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells
The Journal of Immunology·2014·283 cit.·DOI
6
SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
Journal of Translational Medicine·2021·268 cit.·DOI
7
microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C
The EMBO Journal·2011·262 cit.·DOI
8
Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis
PLoS ONE·2019·235 cit.·DOI
9
Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway
Cellular Microbiology·2004·199 cit.·DOI
10
FUS Interacts with HSP60 to Promote Mitochondrial Damage
PLoS Genetics·2015·193 cit.·DOI